Suppr超能文献

普通呼吸疾病人群中的肺部非结核分枝杆菌

Pulmonary non-tuberculous mycobacteria in a general respiratory population.

作者信息

Chong S G, Kent B D, Fitzgerald S, McDonnell T J

出版信息

Ir Med J. 2014 Jul-Aug;107(7):207-9.

Abstract

The prevalence of non-tuberculous mycobacterium (NTM) appears to be increasing. Much of the experience in the literature about this emerging organism comes from specialised units or populations such as cystic fibrosis patients. We, therefore, aim to evaluate the experience in a general respiratory population of dealing with patients with positive culture of NTM. We did a retrospective review of medical notes of general respiratory patients from whom NTM were isolated from January 2007 to July 2012. Cystic fibrosis patients were excluded. We reviewed 37 patients' (19 males, 18 females) medical records. A total of 73 positive cultures were reviewed. 28 isolates were from sputum samples alone, 34 isolates were from bronchoalveolar lavage alone and 11 isolates were from a combination of sputum and bronchoalveor lavage (11 isolates), We found that Mycobacterium avium was the most frequently isolated Mycobacterium in our laboratory with 22 (60%) patients had Mycobacterium avium in their pulmonary cultures. Interestingly, Mycobacterium gordonae and mycobacterium intracellulare were the second commonest mycobacterium (4, 11%) cultured. We noted 2 (5%), cases of Mycobacterium szulgai, 2 (5%) cases of Mycobacterium chelonae and 2 (5%) cases of Mycobacterium abscessus. There was 1(3%) case of Mycobacterium malmoense. There is prevalence of NTM in male COPD patients (7, 89%) and femal bronchiectasis (10, 77%) patients. Of our 8 COPD patients, 6 (75%) were on inhaled corticosteroids while 2 (25%) were not. 9 (24%) patients were smokers, 11 (30%) were ex-smokers, 14 (38%) were non-smokers and the smoking status of the remaining 3 (8%) was unknown. Of the 37 patients, only 6 (16%) received treatment. However, 2 patients stopped their treatment due to treatment toxicity. We concluded that the isolation of NTM is not uncommon. Defining NTM disease is difficult and deciding which patient to be treated needs careful evaluation as treatment can potentially be very toxic.

摘要

非结核分枝杆菌(NTM)的患病率似乎在上升。文献中关于这种新出现病原体的许多经验来自专科单位或特定人群,如囊性纤维化患者。因此,我们旨在评估普通呼吸科人群中处理NTM培养阳性患者的经验。我们对2007年1月至2012年7月从普通呼吸科患者中分离出NTM的病历进行了回顾性研究。囊性纤维化患者被排除在外。我们查阅了37例患者(19例男性,18例女性)的病历。共审查了73份阳性培养物。28份分离株仅来自痰液样本,34份分离株仅来自支气管肺泡灌洗,11份分离株来自痰液和支气管肺泡灌洗的组合。我们发现鸟分枝杆菌是我们实验室中最常分离出的分枝杆菌,22例(60%)患者的肺部培养物中有鸟分枝杆菌。有趣的是,戈登分枝杆菌和胞内分枝杆菌是第二常见的培养分枝杆菌(各4例,占11%)。我们注意到有2例(5%)溃疡分枝杆菌、2例(5%)龟分枝杆菌和2例(5%)脓肿分枝杆菌。有1例(3%)马尔默分枝杆菌。NTM在男性慢性阻塞性肺疾病(COPD)患者(7例,占89%)和女性支气管扩张症患者(10例,占77%)中较为常见。在我们的8例COPD患者中,6例(75%)使用吸入性糖皮质激素,2例(25%)未使用。9例(24%)患者为吸烟者,11例(30%)为既往吸烟者,14例(38%)为非吸烟者,其余3例(8%)的吸烟状况未知。在这37例患者中,只有6例(16%)接受了治疗。然而,2例患者因治疗毒性而停止治疗。我们得出结论,NTM的分离并不罕见。定义NTM疾病很困难,决定哪些患者需要治疗需要仔细评估,因为治疗可能具有很大的毒性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验